Join to view full profile
593 Eddy StApc 5Providence, RI 02903
Phone+1 401-444-4741
Fax+1 401-444-4445
Join Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 6 invites waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Angela Caliendo, MD is an infectious disease specialist in Providence, Rhode Island. She is currently licensed to practice medicine in Rhode Island, New York, and Georgia.
Education & Training
Mass General Brigham/Massachusetts General Hospital/Brigham and Women's HospitalFellowship, Infectious Disease, 1990 - 1994
Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 1987 - 1990
Case Western Reserve University School of MedicineClass of 1987
Certifications & Licensure
RI State Medical License 2012 - 2028
MA State Medical License 1989 - 2027
GA State Medical License 1999 - 2023
NY State Medical License 2010 - 2015
American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- Limited Short-Term Evolution of SARS-CoV-2 RNA-Dependent RNA Polymerase under Remdesivir Exposure in Upper Respiratory Compartments.Vladimir Novitsky, Curt G Beckwith, Kristin Carpenter-Azevedo, Jimin Shin, Joel Hague
Viruses. 2024-09-24 - 1 citationsPlasma Cell-Free DNA Metagenomic Sequencing: New Insights From the PICKUP Study.Kimberly E Hanson, Angela M Caliendo
Clinical Infectious Diseases. 2024-03-20 - Young Female With Hypereosinophilia, Rash, and Gait Disturbance: A Case Report.Praveen Hariharan, Lina Nemchenok, Mohanad Hadi, Vaugh Williams, Angela Caliendo
Cureus. 2024-03-01
Press Mentions
Brown Health Agrees to Add 40,000 Primary Care Patients to Win AG Support for Doc DealSeptember 30th, 2025- AG Leverages Regulatory Review to Tackle Rhode Island’s Primary Care ShortageSeptember 30th, 2025
- Danaher Announces Renowned Scientists to Join New Scientific Advisory BoardApril 26th, 2021
Grant Support
- Novel pan-RAS Inhibitors from Natural Products: A Safer Approach for Colorectal Cancer InterceptionAUBURN UNIVERSITY AT AUBURN2026–2029
- A shared Agilent 6546 LC-QTOF for biomedical researchAUBURN UNIVERSITY AT AUBURN2025–2026
- In vitro assessment of kratom pharmacokinetic CYP interactions with HIV ART drug metabolismAUBURN UNIVERSITY AT AUBURN2023–2025
- Unravelling the mechanism of acai BDS-anticancer drug interaction: A preliminary approachAUBURN UNIVERSITY AT AUBURN2021–2025
